Concepedia

Publication | Open Access

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

2.6K

Citations

19

References

2006

Year

Abstract

As compared with intravenous paclitaxel plus cisplatin, intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel improves survival in patients with optimally debulked stage III ovarian cancer.

References

YearCitations

Page 1